On September 17, 2020 Selvita, one of the largest preclinical contract research organizations in Europe, reported that it will present at the 20th Annual Biotech in Europe Forum For Global Partnering & Investment. Instead of hosting an in-person format, the conference will be delivered as a fully digital event that will take place on the 21-24 September (Press release, Selvita, SEP 17, 2020, View Source;utm_medium=rss&utm_campaign=selvita-to-present-at-the-20th-annual-biotech-in-europe-forum-for-global-partnering-investment [SID1234565420]). The main program is being spread throughout four days and will feature high-level speeches and panel discussions. This event draws together public companies with leading investors, analysts, money managers, and pharma licensing executives.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Edyta Jaworska, Member of the Management Board, Integrated Drug Discovery, is scheduled to present during the panel: Exciting Opportunities in Krakow, Poland – Life Science is Growing Here. The meeting will take place on the 23rd of September at around 4:00 PM CET and will last approximately 30 minutes. The virtual panel will include discussion, a brief presentation by each speaker as well as the Q&A session from the audience.